NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the…
BOSTON, Feb. 25, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) ("TransCode" or the "Company"), the RNA Oncology Company™ committed…
Moncton, New Brunswick and Cambridge, Massachusetts--(Newsfile Corp. - February 25, 2025) - Breathe BioMedical, a company developing a breath analytics…
DELRAY BEACH, Fla., Feb. 25, 2025 /PRNewswire/ -- The global endoscopic ultrasonography market, valued at US$1.28 billion in 2023, is…
Mount Sinai and Kyabirwa Surgical Center Partnership Leverages Cutting-Edge Technology to Revolutionize Surgical Care in Uganda NEW YORK, Feb. 25,…
Global Biospecimen Leader to Unveil Transformative Tool for Oncology Studies HUNTSVILLE, Ala., Feb. 25, 2025 /PRNewswire/ -- Discovery Life Sciences…
300 million single cell atlas now accessible to the scientific community comprised of Vevo's Tahoe-100M, mapping 60,000 drug-patient interactions, and Arc's…
FREMONT, Calif., Feb. 25, 2025 /PRNewswire/ -- Ultima Genomics, Inc., developer of the UG100™ next-generation sequencing (NGS) platform, today announced expanded…
Silexion Completes Data Collection Phase in First-Ever Evaluation of SIL-204 in Clinically Relevant Orthotopic Models; Analysis Underway with Initial Results…
Several subjects who received the highest dose in Phase 1 will also be included in Phase 2OCALA, Fla., Feb. 25,…